Related Experiment Videos
[Epithelial ovarian cancers (advanced stage)]
J P Spano1, E Lucchi, A Sezeur
1Hôpital Pitié-Salpêtrière, SOMPS, 47-83, bd de l'Hôpital, 75013 Paris.
Bulletin Du Cancer
|January 26, 1999
Summary
This overview details ovarian carcinoma management, focusing on familial history, diagnosis, and advanced treatment strategies. It covers prognostic factors and follow-up care for epithelial ovarian cancer and borderline tumors.
Area of Science:
- Oncology
- Gynecologic Oncology
Context:
- Ovarian carcinomas present a poor prognosis due to late diagnosis and high recurrence rates.
- Familial history plays a role in a subset of ovarian cancer cases.
- Advanced staging at diagnosis is common for ovarian cancer.
Purpose:
- To provide a comprehensive overview of ovarian carcinoma management approaches.
- To detail prognostic factors, diagnostic methods, and histologic classifications.
- To discuss recent therapeutic strategies for epithelial ovarian cancer and borderline tumors.
Summary:
- Explains various treatment modalities for ovarian carcinoma, including novel drug combinations with taxanes and platinum derivatives.
- Highlights the importance of considering familial history in ovarian cancer assessment.
- Covers post-treatment management, including follow-up and maintenance therapy.
- Addresses specific considerations for borderline ovarian tumors.
Impact:
- Informs clinicians on current and emerging strategies for managing ovarian cancer.
- Emphasizes the need for early diagnosis and tailored treatment plans.
- Contributes to improved understanding and potential outcomes for ovarian carcinoma patients.